Early treatment with this potent antiviral drug not only reduces the duration and severity of influenza symptoms, it also may help reduce the overall burden of influenza on society. News & Perspective ...

Thus the anti-Influenza activity of NV-387 given orally was substantially superior to all three of the approved anti-influenza drugs, namely Tamiflu, Rapivab, and Xofluza.

The likelihood of antiviral prescribing and dispensing among patients with influenza varied by care setting, patient age, and underlying medical conditions.

Oseltamivir (Tamiflu) has not panned out for reducing the risk of influenza hospitalization, according to a large meta-analysis. Among over 6,000 flu patients across 15 studies, the 0.14 ...

Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and mortality. Current antiviral therapies, such as neuraminidase inhibitors and ...

If oseltamivir is unavailable, outpatients at increased risk for complications who present with uncomplicated influenza can be treated with oral baloxavir, inhaled zanamivir, or intravenous ...

Walgreens told ABC7 that certain stores are experiencing shortages of the prescribed anti-viral drug Tamiflu. ... Some flu medicine, cold remedies running low amid high influenza activity. By ABC7 ...

Objective: To determine the effect of oseltamivir (75mg twice daily) on time to return to baseline health, sleep and activity in patients with laboratory-confirmed influenza infection. Patients ...

Thus the anti-Influenza activity of NV-387 given orally was substantially superior to all three of the approved anti-influenza drugs, namely Tamiflu, Rapivab, and Xofluza. Survival Lifespan of ...